Introduction {#Sec1}
============

More than one and a half centuries after Hutchinson's design of a spirometer to determine the 'capacity for life,' the forced vital capacity (FVC) remains a good predictor of mortality and morbidity. It is related to all-cause mortality even in the general population \[[@CR1], [@CR2]\] and can predict it better than systolic blood pressure or body mass index (BMI) \[[@CR3]\]. Studies from the developed world have also shown significant associations of FVC with cardiovascular disease \[[@CR4], [@CR5]\], cardiovascular events \[[@CR6]\], sudden cardiac death \[[@CR7]\], metabolic syndrome \[[@CR8]\], diabetes \[[@CR9], [@CR10]\], and the progression of chronic kidney disease \[[@CR11]\]. There are relatively few studies that have examined the risk factors for a low FVC though this has often been attributed to "normal" ethnic differences.

Few spirometry based studies have been conducted on the Caribbean population. These studies have focused on airway obstruction and were performed either in specialty clinics or hospital. Two of them showed low forced expiratory volume in one second (FEV1) or FVC associated with vascular disease \[[@CR12], [@CR13]\] and another, FVC with systemic inflammation in diabetic patients \[[@CR14]\].

We studied FVC in a national community-based study of non-institutionalized adults aged 40 years and over and living in Trinidad and Tobago, using the Burden of Obstructive Lung Disease (BOLD) study methodology. We investigated potential risk factors as well as the relation of FVC to the health and socioeconomic status. Since the use of universal cut-offs to define abnormal spirometry is contentious \[[@CR15]\], we have analysed FVC as a continuous variable to assess its associations, including those with age, sex and ethnicity. In addition, we also studied similar associations with pre-bronchodilator FVC; and pre and post-bronchodilator FEV1.

Methods {#Sec2}
=======

Setting {#Sec3}
-------

Trinidad and Tobago, a high human development indexed country in the Caribbean, has a uniquely diverse population of predominantly East Indian and African descent. More than half of the population aged 20 years or more (55.5% of males and 66.1% of females) are overweight and obese \[[@CR16]\]. The country also possesses a high burden of diabetes and cardiovascular diseases which were determined as the top two causes of death and disability in 2016 (Data was sourced from the IHME GBD profile. <http://www.healthdata.org/trinidad-and-tobago>.).

Study design {#Sec4}
------------

A cross-sectional survey was conducted across the 15 administrative districts of Trinidad and Tobago, a country with about 1.3 million inhabitants including 39% aged 40 years and above \[[@CR17]\]. The study was approved by the ethics committees of the Faculty of Medical Sciences of the University of the West Indies and the Ministry of Health, Trinidad and Tobago.

After obtaining consent, participants aged 40 years and above were asked to answer a core questionnaire focusing on respiratory symptoms, health status, activity limitation, use of healthcare services, and exposure to potential risk factors, such as cigarette smoke. The participants also performed spirometry if there were no contraindications for forced expiratory manoeuvres. Additional questionnaires on indoor air pollution and occupational exposures were administered before the post-bronchodilator spirometry manoeuvres. A wealth score, using a Mokken scale \[[@CR18]\] was applied to differentiate the socio-economic status of individual participants. This score was calculated based on the ownership of 10 household assets.

Spirometry {#Sec5}
----------

Spirometry was performed according to the 1994 American Thoracic Society (ATS) criteria \[[@CR19]\], using the Easy-One portable spirometer (ndd Medizintechnik; Zurich, Switzerland), with the participant in a seated position and pre and post-bronchodilator spirometry (15 min after administering 200 μg salbutamol via metered-dose inhaler with a valve spacer) performed following the BOLD methodology \[[@CR20]\]. The difference between the largest and second largest FEV1 and FVC values of \< 200 ml was considered as reproducible \[[@CR20]\]. A plateau for at least one second after an exhalation time of at least 6 s was considered as a valid end-of-test criterion \[[@CR19]\]. Spirometry data were transmitted electronically to the BOLD pulmonary function reading centre in London, where each spirogram was reviewed. A good spirometry had to meet ATS criteria for acceptability, including having at least three attempts, two of which were acceptable \[[@CR21]\]. Spirometry technicians were continuously monitored and whenever their quality scores dropped below a pre-set level, they were asked to stop testing, and undergo retraining and recertification. Among the acceptable efforts, the best post-bronchodilator FEV1 and FVC values, even if they were from different curves were used for statistical analyses \[[@CR19]\].

Sampling {#Sec6}
--------

Participants were selected using two-stage stratified cluster sampling. The study was based on the BOLD protocol that required a minimal sample size of 600 persons above the age of 40 years. The actual sample size, inflated to take into account an expected rate of non-response and unacceptable spirometry (20%) and the clustered nature of the sampling, was 1209 households. A total of 1469 eligible participants were identified from these households and invited to participate.

Statistical analyses {#Sec7}
--------------------

Chi-square tests were used to examine differences in categorical variables and Student's t-test to examine differences in continuous variables. We checked for differences between responders and non-responders and between those with and without acceptable spirometry. Complex Samples General Linear Models (SPSS Version 25) were used to study associations between FVC and the risk factors. This enabled the application of the stratified cluster sampling structure of the data in the analysis. Weights were also used in the analyses. Base weights were calculated as the inverse of the probability of each participant's selection. Final weights were determined by adjusting for the age and gender distribution of the national population, using census data.

Age, sex, height, and height-squared are strong predictors of lung function \[[@CR22]\] and as these four variables accounted for 60.5% of FVC variance, they were entered as covariates in all analyses. Age squared was not a significant predictor in our analyses and was not used as a covariate. Separate analyses were conducted for each risk factor. All the risk factors that were significantly associated with FVC were subsequently entered in a final model to determine independent predictors. We also used General Linear Models to conduct separate regression analyses to examine associations between FVC and the various health status indicators, and respiratory symptoms. The Complex Samples Analysis module was also used to estimate the prevalence and 95% CI for chronic airflow obstruction.

Results {#Sec8}
=======

Out of a total eligible sample of 1469 individuals, 1394 completed the core questionnaire and undertook spirometry. Among them, 1104 successfully performed spirometry, as per the BOLD study quality control criteria (Fig. [1](#Fig1){ref-type="fig"}). Of the individuals approached 95% responded (95% response rate) and of these 97% agreed to participate (97% co-operation rate). Spirometry acceptability rate was 79%. Younger participants, those of Indo-Caribbean descent and those who had no chronic respiratory symptoms had higher rates of acceptable spirometry (*p* \< 0.005 in all cases) (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Smoking status, BMI and the presence of doctor-diagnosed respiratory disease did not show association with the participants' spirometry acceptability.Fig. 1Sampling of participants in the BOLD-Trinidad and Tobago study

The majority of participants were females (60%), and the sample's age and ethnic distributions matched well with the recent national census data \[[@CR17]\]. Overall, the sample comprised mainly persons of Asian or African ancestry (78%), with secondary or higher level education (53%), who were overweight or obese (70%), and who were exposed to indoor air pollutants (55%) (Table [1](#Tab1){ref-type="table"}). Mean BMI and waist circumferences were higher among Afro-Caribbeans than Indo-Caribbeans (29.59 kg/m^2^ vs. 27.90 kg/m^2^; 97.71 cm vs. 95.71 cm, respectively; *p* \< 0.03 in all cases). 27% of the participants gave a history of smoking, which was four times more prevalent in males than females. Among the smokers, more than half were current smokers and one third had also smoked cannabis. 85% of participants had ownership of eight or more of the household amenities in the inventory.Table 1Demographics, anthropometry, smoking history and indoor air pollutant exposure of the BOLD Trinidad and Tobago study participantsVariableMale (443)Female (661)Total (1104)Age in years 40--49152 (34.3%)287 (43.4%)439 (39.8%) 50--59145 (32.7%)193 (29.2%)338 (30.6%) 60--6990(20.3%)117 (17.7%)207 (18.8%) 70+56 (12.6%)64 (9.7%)120 (10.9%)Ethnicity Indo-Caribbean191 (43.1%)269 (40.7%)460 (41.7%) Afro-Caribbean169 (38.1%)233 (35.2%)402 (36.4%) Mixed/ other83 (18.7%)159 (24.1%)242 (21.9%)Highest completed level of education Primary /none205 (46.8%)314 (47.5%)521 (47.2%) Secondary134 (30.2%)216 (32.7%)350 (31.7%) Vocational79 (17.8%)90 (13.6%)169 (15.3%) University23 (5.2%)41 (6.2%)64 (5.8%)Employment status Employed287 (64.8%)328 (49.6%)615 (55.7%) Not working17 (3.5%)23 (3.5%)40 (3.6%) House-person7 (1.6%)208 (31.5%)215 (19.5%) Retired122 (27.5%)88 (13.3%)210 (19.0%) Other10 (2.3%)14 (2.1%)24 (2.2%)Wealth score (Mean (SD))8.85 (1.62)9.03 (1.31)8.96 (1.44)BMI groups Underweight (\< 18.5 kg/m^2^)11 (2.5%)15 (2.3%)26 (2.4%) Normal (18.5--24.9 kg/m^2^)162 (36.6%)146 (22.1%)308 (27.9%) Overweight (25--29.9 kg/m^2^)174 (39.3%)207 (31.3%)381 (34.5%) Obese (≥30 kg/m^2^)96 (21.7%)293 (44.3%)389 (35.2%)Waist circumference Normal300 (67.7%)162 (24.5%)461 (41.8%) Abnormal (≥102 cm for males, ≥88 cm for females)143 (32.3%)499 (75.4%)642 (58.2%)Waist Hip ratio Normal152 (34.4%)205 (31.0%)357 (32.4%) Abnormal (\> 0.9 for males, \> 0.85 for females)290 (65.6%)456 (68.9%)746 (67.6%)Smoking status Current121 (27.3%)36 (5.4%)157 (14.2%) Former104 (23.5%)41 (6.2%)145 (13.1%) Never218 (49.2%)584 (88.4%)802 (72.6%)Pack-year categories Never219 (49.5%)584 (88.4%)803 (72.8%) 0--1067 (15.2%)35 (5.3%)102 (9.2%) 10--2056 (12.7%)21 (3.2%)77 (7.0%) 20 +100 (22.6%)21 (3.2%)121 (11.0%)Ever smoked cannabis72 (16.3%)24 (3.6%)96 (8.7%)Exposure to second hand smoke152 (34.3%)220 (33.3%)372 (33.7%)Working in a dusty environment for \> 1 year238 (53.7%)161 (24.4%)399 (36.1%)Indoor open fire with coal used for cooking87 (19.9%)99 (15.1%)186 (17.0%)Indoor open fire with wood used for cooking188 (42.9%)249 (37.9%)437 (39.9%)Kerosene used for cooking163 (37.2%)249 (37.9%)412 (37.6%)Indoor air pollutant exposure: coal, wood or kerosene Exposure to one126 (28.4%)179 (27.1%)305 (27.6%) Exposure to two75 (16.9%)125 (18.9%)200 (18.1%) Exposure to all three54 (12.2%)56 (8.5%)110 (10.0%) None188 (42.4%)301 (45.5%)489 (44.3%)Data are presented as n (%) if not stated otherwise

About one-third of the study participants mentioned at least one of the four symptoms - cough, phlegm, wheeze, and breathlessness in the past 12 months. Also, nearly 10% reported a doctor diagnosed respiratory disease (Table [2](#Tab2){ref-type="table"}). 37% had at least one known co-morbidity, the most prevalent conditions being hypertension (28%) and diabetes (15%). Indo-Caribbeans had a higher diabetes prevalence than the Afro-Caribbeans and Mixed/ other ethnic groups (21, 10, and 12% respectively). This is the only health variable observed to be different between the ethnic groups. Gender differences in health status were noted in breathlessness, (*p* \< 0.001) and doctor-diagnosed respiratory diseases (*p* = 0.03). In each case, the rates were higher in women than in men (Table [2](#Tab2){ref-type="table"}).Table 2Health variables of BOLD Trinidad and Tobago study participantsVariableMale (443)Female (661)Total (1104)Chronic cough30 (6.8%)52 (7.9%)82 (7.4%)Chronic phlegm13 (2.9%)27 (4.1%)40 (3.6%)Wheezing in last 12 months44 (9.9%)85 (12.9%)129 (11.7%)Breathlessness54 (12.5%)136 (21.7%)190 (17.9%)Symptomatic (any single respiratory symptom)134 (30.2%)248 (37.5%)382 (34.6%)Self-reported chronic bronchitis5 (1.1%)11 (1.7%)16 (1.4%)Doctor diagnosed COPD, chronic bronchitis or emphysema3 (0.7%)14 (2.1%)17 (1.5%)Doctor diagnosed asthma34 (7.7%)75 (11.3%)109 (9.9%)Doctor diagnosed respiratory disease35 (7.9%)79 (12.0%)114 (10.3%)Doctor diagnosed any other medical condition146 (33.0%)255 (38.6%)401 (36.3%)Doctor diagnosed heart disease27 (6.1%)33 (5.0%)60 (5.4%)Heart failure12 (2.7%)10 (1.5%)22 (2.0%)Hypertension112 (25.3%)202 (30.6%)314 (28.4%)Diabetes59 (13.3%)109 (16.5%)168 (15.2%)Stroke5 (1.1%)4 (0.6%)9 (0.8%)Lung cancer0 (0%)1 (0.2%)1 (0.1%)Tuberculosis0 (0%)0 (0%)0 (0%)Presence of any single comorbidity147 (33.2%)257 (38.9%)404 (36.6%)Hospitalised as a child for breathing problems prior age 106 (1.4%)10 (1.5%)16 (1.5%)Data are presented as n (%)

Risk factors for low FVC {#Sec9}
------------------------

FVC values were higher in men than women (mean difference = 1070 ml; 95%CI = 991, 1148; *p* \< 0.001). These values were also positively correlated with height (b = 0.052; 95%CI = 0.047, 0.056; *p* \< 0.001) and negatively associated with age (b = − 0.026; 95%CI = − 0.031, − 0.021; *p* \< 0.001).

The mean FVC and FEV1 values adjusted for age, sex, height, and height-squared are tabulated in Table [3](#Tab3){ref-type="table"} by the potential risk factors. There were significant post-bronchodilator FVC differences by ethnicity (*p* \< 0.001), BMI group (*p* = 0.024), abnormal waist circumference (*p* \< 0.001), abnormal waist-hip-ratio (*p* \< 0.001), and whether they smoked cannabis (*p* = 0.004). Indo-Caribbeans showed lower mean FVCs than Afro-Caribbeans and other ethnic groups (Table [3](#Tab3){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}). BMI presented a non-linear relation with low FVC. Underweight and obese subjects displayed lower FVCs than those with normal body habitus and overweight people. People with central obesity (abnormal waist circumference and waist-hip ratio) also showed lower FVCs. On the other hand, smokers of cannabis had higher FVC scores than persons who never smoked cannabis. Cigarette smoking status, history of pack-years, second-hand smoking, childhood exposure to smoking, indoor air pollutant exposure, and working in a dusty environment for more than 1 year were not associated with FVC values.Table 3Mean adjusted^a^ pre and post-bronchodilator (BD) forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) values (in ml) by the various potential risk factorsVariableAdjusted Pre-BD Mean FEV1Adjusted Post-BD Mean FEV1Adjusted Pre-BD Mean FVCAdjusted Post-BD Mean FVCEthnicity\*\*\*\*\*\*\*\*\*\*\*\* Indo-Caribbean2085213326612669 Afro-Caribbean2212226828532880 Mixed/ other2284233129512952BMI group\*\* Underweight (\< 18.5 kg/m^2^)2098214627392736 Normal (18.5--24.9 kg/m^2^)2198223928592845 Overweight (25--29.9 kg/m^2^)2200225728212852 Obese (≥30 kg/m^2^)2119217526932718Waist circumference\*\*\*\*\*\*\*\*\*\*\*\*Normal2261230029232917Abnormal^b^2094215826742710Waist Hip ratio\*\*\*\*\*\*\*\*\*\*\*\* Normal2263230829282919 Abnormal^c^2126218227212748Smoking status Current smoker2157224228342894 Ex-smoker2158219627572769 Never smoker2176222327842791Smoking pack years Never2176222327832790 0--102217224728092819 10--202152223227952824 20+2109219227872852Smoking and respiratory symptoms\* Never smoker with no symptoms2201225728122819 Never smoker with symptoms2119214827202725 Ever smoker with no symptoms2211226128592876 Ever smoker with symptoms2087217327172780Ever smoked cannabis\*\*\* No2167222027772791 Yes2255230229842996Second-hand smoking No2176223427732817 Yes2160220027962777Indoor air pollutant exposure (coal, wood or kerosene)\*\*\* None2203224928382846 Exposure to one2119218827122742 Exposure to two2223226628212831 Exposure to all three2089213227352753Worked in a dusty environment for \> 1 year No2183222727802784 Yes2150221628032835Smoking exposure during childhood\* No2207225028012818 Yes2144220327722794Highest level of education\*\*\*\*\*\*\* Primary/none2137219727472775 Secondary2159221227782805 Vocational2228225928472819 University2363239730272974Education -- years of schooling\* 0--6 years2073216226802730 7+ years2182223028012811Current employment status Employed2195224028052815 Not working2152223727882880 House person2140221527172753 Retired2111216427722775 Other2361236230823024Significant *p*-values are shown and denoted by \* \< 0.05; \*\* \< 0.005; \*\*\* \< 0.001^a^Adjusted for age, sex, height and height-squared with covariates were fixed at the following values: Sex = 0.49; height = 166.43; height-squared = 27,818.0145; Age = 54.93^b^Abnormal waist circumference: ≥102 cm for males and ≥ 88 cm for females^c^Abnormal waist hip ratio: \> 0.9 for males, \> 0.85 for femalesFig. 2Mean post-bronchodilator FVCs adjusted for age, sex, height and height square among various groups that are statistically significant (*p* \< 0.05). Bars represent the mean FVC in millilitres and error bars the 95% CI

Multiple regression analysis of the risk factors that were significant after adjusting for age, sex, height, and height-squared indicated that post-bronchodilator FVC was lower in those with increased waist circumference (− 172 ml), Indo-Caribbean participants (− 180 ml) and those who were underweight (− 185 ml), and higher in those who smoked cannabis (+ 155 ml) (Table [4](#Tab4){ref-type="table"}).Table 4Results of the general linear models analyses for the significant risk factors for post-bronchodilator forced vital capacity (FVC)VariablesCategoriesModels with Individual Risk Factors^a^Multivariate Model^a^p-values (Multivariate model)Coefficient (ml)95% CICoefficient (ml)95% CIEthnicityAfro-CaribbeanBaseline\< 0.001Indo-Caribbean−211−302−120−180−269−90Mixed/Other73−3518079−27185BMI^b^NormalBaseline0.01Underweight−109−26144−185−330−40Overweight8−779368−24161Obese− 127−228−26−15−12898Abnormal waist circumference^c^Yes−207− 296−119−172−278−66\< 0.001Abnormal waist--hip ratio ^d^Yes− 170− 246−95−71−14520.057Ever smoked cannabisYes20567342155272820.018^a^All models included sex, age, height and height-squared. ^b^Normal BMI = 18.5--25.0 Kg/m^2^; Underweight BMI \< 18.5 Kg/m^2^; Overweight BMI = 25.0--29.9 Kg/m^2^; Obese BMI ≥30 Kg/m^2^. ^c^**:** Abnormal waist circumference ≥ 102 cm for males and ≥ 88 cm for females. ^d^: Abnormal wait-hip ratio ≥ 0.90 for males and ≥ 0.85 for females

Risk factors for low pre-bronchodilator FVC were of similar significance to those for post-bronchodilator FVC except that indoor air pollution and levels of education were related to pre-bronchodilator FVC but not to post-bronchodilator FVC (Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Table S2).

FVC and health variables {#Sec10}
------------------------

The mean adjusted FVC and FEV1 scores by the various symptoms and health status variables are listed in Table [5](#Tab5){ref-type="table"}. Participants with known diabetes (*p* = 0.041), with a history of breathlessness (*p* = 0.007), and wheeze in the past 12 months (*p* = 0.040) exhibited lower FVC. Diagnosed respiratory disease, hypertension, cardiac disease, history of cough or phlegm, hospitalization before the age of 10 years, and family history of airway disease were not associated with FVC.Table 5Mean adjusted^a^ pre and post bronchodilator (BD) forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) values (in ml) by the various health variablesVariableAdjusted Pre-BD Mean FEV1Adjusted Post-BD Mean FEV1Adjusted Pre-BD Mean FVCAdjusted Post-BD Mean FVCHospitalisations prior to the age 10\* No2171222327862801 Yes2246224430423032Known asthma\*\*\*\*\*\* No2192224228002812 Yes1967204926752727Known respiratory disease\*\*\*\*\*\*\* No2195224428032815 Yes1955203726542707Known hypertension No2153219728062820 Yes2177223327412764Known diabetes\*\* No2127216628022818 Yes2179223327092727Known cardiac disease No2084213227952813 Yes2176222826732662Presence of any known comorbidity\* No2184223628142824 Yes2146219927422770Chronic cough No2173222627842799 Yes2133218228072827Phlegm No2172222327922806 Yes2143220827552783Wheeze in the last 12 months\*\*\*\*\*\*\*\*\*\* No2200224728152821 Yes1946204125792681Breathlessness\*\*\*\*\*\*\*\* No2216227028372850 Yes2071212126782708Family history of airway disease No2167222027822799 Yes2272228129282919Significant *p*-values are shown and denoted by \* \< 0.05; \*\* \< 0.005; \*\*\* \< 0.001^a^Adjusted for age, sex, height and height-squared with covariates were fixed at the following values: Sex = 0.49; height = 166.43; height-squared = 27,818.0145; Age = 54.93

Risk factors for low FEV1 {#Sec11}
-------------------------

Low post-bronchodilator FEV1 was also independently associated with Indo-Caribbean ethnicity (− 125 ml) and abnormal waist circumference (− 108 ml) (Additional file [1](#MOESM1){ref-type="media"}: Table S4). In contrast to FVC, low FEV1 showed an independent association with indoor air pollutant exposure (− 95 ml for all three exposures) but did not show a relation with BMI and cannabis smoking. Further, pre-bronchodilator FEV1 showed associations with abnormal waist-hip ratio (− 69 ml) and highest level of education (+ 168 ml for university education).

Discussion {#Sec12}
==========

To our knowledge this is the first published study of lung function in the general population of a Caribbean country and provides new information on the associations of FVC with participant demographics, socio-economic status and morbidity. We found lower FVCs among the Indo-Caribbean population, those with a low BMI and with central obesity. Individuals with a low FVC had more respiratory symptoms.

We observed low FVCs among Indo-Caribbeans compared to Afro-Caribbeans in our study by abut 8% despite the similar prevalence of abnormal waist circumference (57.0% vs. 58.7%; *p* = 0.751) and a lower prevalence of obesity (30.0% vs. 41.8%; *p* = 0.008), (Table [6](#Tab6){ref-type="table"}). The lower volumes among Indo-Caribbeans compared with the population of African descendant were consistent with the results from Global differences in lung function by region Prospective Urban Rural Epidemiology (PURE) study \[[@CR23]\]. This contrasts with the recently published Canadian Health Measures Survey reference values \[[@CR24]\] which showed higher FVCs among those of South Asian compared with those of African descent.Table 6Risk Factors by Ethnicity: Afro-Caribbean (*n* = 402) vs. Indo-Caribbean (*n* = 460) vs. Mixed/Others (*n* = 242)VariableAfro-CaribbeanIndo-CaribbeanMixed/ Othersp-valueGender0∙110 Male169 (42.0%)191 (41.5%)83 (34.3%) Female233 (58∙0%)269 (58.5%)159 (65.7%)Age group0.076 40--49145 (36.1%)181 (39.3%)113 (46.7%) 50--59134 (33.3%)136 (29.6%)68 (28.1%) 60--6980 (19.9%)95 (20.7%)32 (13.2%) 70+43 (10.7%)48 (10.4%)29 (12.0%)BMI group^a^0.008 Underweight7 (1.7%)10 (2.2%)9 (3.7%) Normal93 (23.1%)145 (31.5%)70 (28.9%) Overweight134 (33.3%)167 (36.3%)80 (33.1%) Obesity168 (41.8%)138 (30.0%83 (34.3%)Waist circumference^b^0.751 Abnormal236 (58.7%)262 (57.0%)144 (59.8%)Waist-Hip ratio^c^\< 0.001 Abnormal238 (59.2%)352 (76.5%)156 (64.7%)Smoking status0.240 Current56 (13.9%)61 (13.3%)40 (16.5%) Ex54 (13.4%)52 (11.3%)39 (16.1%) Never292 (72.6%)347 (75.4%)163 (67.4%)Smoking pack years0.244 Never293 (72.9%)347 (75.6%)163 (67.4%) 0--1035 (8.7%)41 (8.9%)26 (10.7%) 10--2025 (6.2%)28 (6.1%)24 (9.9%) 20+49 (12.2%)43 (9.4%)29 (12.0%)Ever smoked Cannabis\< 0.001 Yes49 (12.6%)19 (4.2%)28 (11.7%)Exposure to second-hand smoke0∙001 Yes112 (27.9%)184 (40.0%)76 (31.4%)Indoor air pollutant exposure\< 0.001 Yes198 (49.2%)310 (67.3%)107 (44.2%)Worked in dusty environment \> 1 year0.001 Yes174 (43.3%)153 (33.3%)72 (29.8%)Smoking exposure during childhood0∙740 Yes234 (58.2%)261 (56.8%)146 (60.3%)Have respiratory symptoms0.335 Yes128 (31.8%)165 (35.8%)89 (36.7%)Highest level of education\< 0.001 Primary / None190 (47.3%)243 (52.8%)88 (36.4%) Secondary113 (28.1%)144 (31.3%)93 (38.4%) Vocational72 (17.9%)54 (11.7%)43 (17.8%) University27 (6.7%)19 (4.1%)18 (7.4%)Years of schooling0.200 7 or more368 (91.5%)405 (88.0%)220 (90.9%)Current employment status\< 0.001 Employed241 (60.0%)241 (52.4%)133 (55.0%) Not working16 (4.0%)9 (2.0%)15 (6.2%) House person34 (8.5%)139 (30.2%)42 (17.4%) Retired95 (23.6%)69 (15.0%)46 (19.0%) Other16 (4.0%)2 (0.4%)6 (2.5%)Data are presented as n (%). *BMI* body mass index. ^a^Normal BMI = 18.5--25.0 Kg/m^2^; Underweight BMI \< 18.5 Kg/m^2^; Overweight BMI = 25.0--29.9 Kg/m^2^; Obese BMI ≥30 Kg/m^2^. ^b^Abnormal waist circumference: ≥ 102 cm for males and ≥ 88 cm for females. ^c^: Abnormal wait-hip ratio ≥ 0.90 for males and ≥ 0.85 for females

FVC in our population showed a nonlinear relation with BMI, comprising low volumes among those with both low and high BMI. Obesity and abnormal waist circumference related reduction in vital capacity can be explained by restriction of inspiration. Obesity-associated reduction in FVC has been observed in many studies and has been attributed to an increased impedance of the chest wall \[[@CR25]--[@CR27]\]. Studies have also shown that a 1 cm increment in waist circumference can decrease FVC by 13 ml \[[@CR28]\]. Waist circumference is considered as a superior indicator of intra-abdominal fat \[[@CR29]\] and may be a good gauge of its effect on diaphragm function and other ventilatory mechanics. When we adjusted FVC measures for both BMI and waist circumference the association of low FVC with a high BMI disappeared and that with waist circumference was essentially unchanged, suggesting that the link between a low FVC and a high BMI is mediated largely through mechanical effects of an increase in intra-abdominal fat. The association of a low FVC with a low BMI, however, was strengthened in the adjusted model, suggesting a more direct association. Low vital capacities have also been reported to be associated with low birth weight \[[@CR30]\], though we have no estimate of birth weight in this population.

An increased FVC among cannabis smokers has also been reported in previous studies \[[@CR31]--[@CR33]\]. The exact cause for this increase is unclear but could reflect a "healthy smoker" effect, those with poor lung function being less likely to take up smoking cannabis. The effect of cannabis on FVC and the lack of association with FEV1 could be explained by training effects on the respiratory muscles with the habitual deep inhalations during cannabis smoking, and the likely acute bronchodilatory effects of delta-9-tetrahydrocannabinol (THC) \[[@CR34]\]. These findings warrant careful interpretation given the potential adverse public health implications of long-term cannabis use including emphysematous bullae \[[@CR35]\] and a twofold increased odds of obstructive lung disease \[[@CR32]\]. Apart from cigarette smoking, the statistically nonsignificant associations with environmental factors such as exposure to indoor air pollution or solid fuel and working in a dusty environment on FVC have been observed in other studies as well \[[@CR36]\].

We found that participants who had a low FVC had a history of wheezing or shortness of breath. This relationship has been published in previous studies \[[@CR37], [@CR38]\]. A low FVC was also associated with comorbidities especially diabetes. Earlier studies have found that individuals in the lowest quartile for FVC are more likely to develop insulin resistance \[[@CR8]\] and diabetes \[[@CR9]\] over time. A meta-analysis of 40 publications has shown a significantly lower FVC and FEV1 with preserved FEV1/FVC ratio among diabetic patients \[[@CR39]\].

Although low socioeconomic status and poor education have been associated with reduced ventilatory function and chronic lung disease, this was not found in the current study. This may be due to either high per capita gross domestic product (GDP US\$ 17,879 in 2015) with minor economic inequalities (GINI index 40.3 in 2010) among the local community (Data was sourced from the IMF press release no. 17/423. <http://www.imf.org/en/News/Articles/2017/11/06/pr17423-imf-executive-board-concludes-article-iv-consultation-with-trinidad-and-tobago>) compared to other developing countries or ineffectiveness of the tools used to distinguish the economic variations in this population. Although the wealth scale that we used has been shown to have good reliability \[[@CR18]\] and has been associated with educational attainment, the majority of the sample possessed eight or more out of ten household amenities. This was similar to the situation seen in wealthy countries like Saudi Arabia \[[@CR40]\]. The scale may need customization.

Limitations of the current study include the cross-sectional nature of the research, reliance on self-reported data and limited tools to measure the socioeconomic variations in the local population. However, there were many strengths such as our high response and cooperation rates. The diverse and evenly distributed ethnic distribution in the population, which was reflected in the sample, allowed for the examination of ethnic differences. Other strengths included the application of robust BOLD methodology, sound participant sampling, and quality assured spirometry. Most importantly we avoided the arbitrary use of 'normal' values for lung function assessment.

Conclusions {#Sec13}
===========

Low FVC was associated with ethnicity, central obesity, chronic respiratory symptoms, and comorbidities like diabetes. Longitudinal studies are required to estimate the mortality and morbidity risk with diminished FVCs and also to compare the health effects of reduced FVC compared to reduced static lung volumes. Identifying individuals with low FVC may have clinical and public health importance and a better understanding of this condition and its origins is needed.
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